BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29902251)

  • 1. Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
    Kami-Onaga K; Tateyama M; Kinjo T; Parrott G; Tominaga D; Takahashi-Nakazato A; Nakamura H; Tasato D; Miyagi K; Maeda S; Arae H; Uehara H; Miyagi K; Haranaga S; Fujita J
    PLoS One; 2018; 13(6):e0199106. PubMed ID: 29902251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
    Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
    AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the International HIV Dementia Scale in the current era.
    Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
    AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
    Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
    Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
    Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
    J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART).
    Merlini E; Iannuzzi F; Calcagno A; Bai F; Trunfio M; d'Arminio Monforte A; Bonora S; Marchetti G
    J Neurovirol; 2018 Dec; 24(6):679-694. PubMed ID: 29987585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.
    Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY
    HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.
    Cross S; Önen N; Gase A; Overton ET; Ances BM
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1114-22. PubMed ID: 24114509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An exploratory study on the diagnostic cutoff value of International HIV-associated Dementia Scale in minority ethnic groups with different educational levels, in Guangxi].
    Zhao TT; Feng QM; Liang H; Tang XY; Wei B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1101-4. PubMed ID: 22336543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International HIV Dementia Scale: a new rapid screening test for HIV dementia.
    Sacktor NC; Wong M; Nakasujja N; Skolasky RL; Selnes OA; Musisi S; Robertson K; McArthur JC; Ronald A; Katabira E
    AIDS; 2005 Sep; 19(13):1367-74. PubMed ID: 16103767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.
    Njamnshi AK; Djientcheu Vde P; Fonsah JY; Yepnjio FN; Njamnshi DM; Muna WE
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):393-7. PubMed ID: 19186351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the International HIV dementia scale in Brazil.
    Rodrigues RA; Oliveira RL; Grinsztejn B; Silva MT
    Arq Neuropsiquiatr; 2013 Jun; 71(6):376-9. PubMed ID: 23828527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
    J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.
    Goodkin K; Hardy DJ; Singh D; Lopez E
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):352-8. PubMed ID: 26037857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.